Lifecode
SVBio rebranded as Lifecode, Inc., focusing on the genetic basis of human disease, particularly in oncology.
Launch date
Employees
Market cap
-
Enterprise valuation
$82—123m (Dealroom.co estimates Feb 2015.)
Foster City California (HQ)
Date | Investors | Amount | Round |
---|---|---|---|
N/A | Early VC | ||
$20.5m | Series A | ||
* | N/A | Acquisition | |
Total Funding | $20.5m |
Recent News about Lifecode
EditTech stack
Tech stackLearn more about the technologies and tools that this company uses.